IBD in hispanics: Characterization of response to infliximab in an ethnic minority with Crohn's disease

被引：0
作者：
Sanchez, JM [1 ]
Maldonado, JC [1 ]
Torres, EA [1 ]
机构：
[1] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 10期
关键词：
D O I：
10.14309/00000434-200410001-00763
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
767
引用
收藏
页码：S248 / S249
页数：2
相关论文
共 50 条
  • [41] Efficacy evaluation and predictors of response to infliximab in patients with Crohn's disease
    Wang, Yufang
    Ouyang, Qin
    Wen, Zhonghui
    Hu, Renwei
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 373 - 373
  • [42] Infliximab and the bone in Crohn's disease
    Kunisaki, R
    Chaki, O
    Taguchi, T
    Sugiyama, T
    Sugita, A
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) : 789 - 790
  • [43] Halting infliximab in Crohn's disease
    Baker, Holly
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (09): : 793 - 793
  • [44] What Is the Rate of Loss of Response to Infliximab Therapy in Crohn's Disease?
    Chao, Jingdong
    Mulani, Parvez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (09) : 2353 - 2354
  • [45] Azathioprine and smoking status in Crohn's disease predict response to infliximab
    Arnott, IDR
    Satsangi, J
    [J]. GUT, 2003, 52 : A13 - A13
  • [46] Does Smoking Decrease the Response to Infliximab in Patients with Crohn's Disease?
    Parsi, Mansour A.
    [J]. INFLAMMATORY BOWEL DISEASES, 2008, 14 : S18 - S19
  • [47] Molecular mechanisms of infliximab response in Crohn's disease (CD) patients
    Mah, Nancy
    Pierrou, Stefan
    Hammer, Marten
    Nikolaus, Susanna
    Kuhbacher, Tanja
    Skogman, Eva
    Stalhult, Lars
    Astrand, Magnus
    Kerick, Martin
    Hasler, Robert
    Costello, Christine
    Thelin, Anders
    Mellgard, Bjorn
    Lagerstrom-Fermer, Maria
    Schreiber, Stefan
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A555 - A556
  • [48] Probiotics can improve the infliximab response for patients with Crohn's disease
    Dai, S.
    Fu, Y.
    Huang, H.
    Chen, Z.
    Xing, T.
    Zhan, Y.
    Sha, W.
    [J]. HELICOBACTER, 2018, 23
  • [49] Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease
    Bortlik, Martin
    Duricova, Dana
    Malickova, Karin
    Machkova, Nadezda
    Bouzkova, Eva
    Hrdlicka, Ludek
    Komarek, Arnost
    Lukas, Milan
    [J]. JOURNAL OF CROHNS & COLITIS, 2013, 7 (09) : 736 - 743
  • [50] Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease
    Fefferman, DS
    Lodhavia, PJ
    Alsahli, M
    Falchuk, KR
    Peppercorn, MA
    Shah, SA
    Farrell, RJ
    [J]. INFLAMMATORY BOWEL DISEASES, 2004, 10 (04) : 346 - 351
12345